Inhibition of fatty acid synthesis in vivo, both targeting ACACA with TOFA or FASN with either Orlistat or UB006, not only reduced tumor growth, but importantly led to neural differentiation, as assessed by expression of differentiation markers. The gene discussed is ACACA; the disease is neoplasm.